Climate Impact of Inhaler Formularies - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Environmental Effects of Inhaler Formulations

  • By

  • William B. Feldman

  • September 28, 2026

Share

Objective:

To examine the environmental impact of inhaler formulations used for asthma and COPD and the barriers to adopting lower-emission alternatives.

Approach:
  • Emission Comparison: Inhalers for asthma and COPD in the US generate emissions comparable to 530,000 cars annually.
  • Insurance Coverage Analysis: Studies assessed the coverage of inhalers by insurance plans, highlighting the limited availability of dry powder alternatives.
  • Cost Analysis: Investigated the out-of-pocket costs associated with different inhaler types and their impact on patient access.
Key Findings:
  • SABAs, ICSs, and ICS-LABAs together represent 98% of inhaler-associated emissions.
  • Only 33% of insurance plans cover dry powder SABAs, limiting patient access.
  • Metered-dose inhalers are generally cheaper than dry powder alternatives, influencing formulary coverage.
Interpretation:

Market competition and pricing structures significantly affect the availability and use of lower-emission inhalers.

Limitations:
  • Existing insurance and payment structures may hinder the adoption of environmentally friendly inhalers.
  • Potential increases in costs for insurers and patients if dry powder inhalers are mandated for coverage.
Conclusion:

Comprehensive policy reform is necessary to balance environmental concerns with patient access and costs in inhaler therapies.

Sources:

Original Source(s)

Related Content